Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 300 shares, a drop of 88.9% from the May 15th total of 2,700 shares. Currently, 0.0% of the company's shares are sold short. Based on an average trading volume of 11,200 shares, the days-to-cover ratio is presently 0.0 days.
Aspen Pharmacare Price Performance
APNHY remained flat at $6.80 during midday trading on Friday. Aspen Pharmacare has a 12-month low of $5.76 and a 12-month high of $13.69. The company has a current ratio of 1.81, a quick ratio of 1.07 and a debt-to-equity ratio of 0.30. The stock's fifty day moving average price is $7.00 and its two-hundred day moving average price is $8.46.
About Aspen Pharmacare
(
Get Free Report)
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Read More
Before you consider Aspen Pharmacare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.
While Aspen Pharmacare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.